Skip to content

Clinical trials

Enrolling by invitation Myelodysplastic Syndromes trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myelodysplastic Syndromes Status: Enrolling by invitation Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20081
20111
20151
20191
20231
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Enrolling by invitation9

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Janssen Research & Development, LLC1
Michael Pulsipher1
National Cancer Institute (NCI)1
National Heart, Lung, and Blood Institute (NHLBI)1
OHSU Knight Cancer Institute1
Ryvu Therapeutics SA1
Taiho Oncology, Inc.1
The First Affiliated Hospital of Soochow University1
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myelodysplastic Syndromes9
Leukemia, Myeloid, Acute6
Lymphoma, Non-Hodgkin2
Precursor Cell Lymphoblastic Leukemia-Lymphoma2
Anemia, Aplastic1
Bone Marrow Diseases1
Bone Marrow Failure Disorders1
Hemoglobinuria, Paroxysmal1
Hodgkin Disease1
Leukemia, Lymphocytic, Chronic, B-Cell1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.